Pfizer
$37.609876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$37.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.38 (+1.01%) As of 2:57 PM EST today
+$0.38 (+1.01%) Today
Why Robinhood?
You can buy or sell Pfizer and other stocks, options, ETFs, and crypto commission-free!
About PFE
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. Read More The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Employees
92,400
Headquarters
New York, New York
Founded
1849
Market Cap
205.98B
Price-Earnings Ratio
13.01
Dividend Yield
3.16
Average Volume
21.00M
High Today
$37.62
Low Today
$37.32
Open Price
$37.39
Volume
14.73M
52 Week High
$46.47
52 Week Low
$33.97
Collections
PFE News
BenzingaNov 18
Castor Establishes Advisory Board of Industry Leaders to Maximize the Impact of Its Clinical Data Platform
AMSTERDAM and HOBOKEN, New Jersey, Nov. 18, 2019 /PRNewswire/ -- Castor, a health-tech company that aims to leverage machine readable data to increase clinical
Analyst Ratings
38%
of 13 ratings
Buy
38%
Hold
62%
Sell
0%
PFE Earnings
$0.62
$0.70
$0.77
$0.85
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Jan 28, Pre-Market
